NCT06215261 - An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Post Traumatic Stress Disorder

Interventions

DRUG

Methylone

Methylone capsules, given orally, once a week for 3 weeks (Part A) or 4 weeks (Part B)

Trial Locations (12)

Ramsay Clinic Albert Road, Melbourne

Swinburne University of Technology, Hawthorn

Sunstone Medical, Rockville

Accel Research, Maitland

CNS Healthcare, Orlando

Segal Trials, Lauderhill

Uptown Clinical Research, Chicago

Numinus, Draper

Redbird Research LLC, Las Vegas

Seattle NTC, Bellevue

Monarch Mental Health Group, Melbourne

Clerkenwell Health, London